Shuohua Chen
Shuohua Chen publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiovascular Health and Disease Prevention and Blood Pressure and Hypertension Studies.
- World rank
- #187,111 of 7,710,434 ranked researchers
- Rank in China
- #18,672 of 978,568
- Works
- 526
- Citations
- 11k
- Citations per work
- 21.2
What does Shuohua Chen research?
Shuohua Chen's work is mostly in Medicine (65%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences34164.9%
- Medicine34164.9%
- Everything else18535.1%
- 1Cardiology and Cardiovascular Medicine26% of their works
- 2Endocrinology, Diabetes and Metabolism14% of their works
- 3Epidemiology9% of their works
- 4Nephrology6% of their works
- 5Surgery5% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Liver Disease Diagnosis and Treatment
- Cardiovascular Health and Risk Factors
- Adipokines, Inflammation, and Metabolic Diseases
- Gout, Hyperuricemia, Uric Acid
- Lipoproteins and Cardiovascular Health
Which keywords describe Shuohua Chen's research?
The keywords of their largest research topics: Metabolic Syndrome, Cardiovascular Disease, Insulin Resistance, Hypertension, Obesity, Cardiovascular Events, Diabetes and Glucose Metabolism.
- Uric Acid
- Hyperuricemia
- Adipose Tissue
- Ideal Cardiovascular Health
- NASH
- Blood Pressure
- Inflammation
- Pulse Wave Velocity
- Risk Factors
- Glucose Metabolism
- Cardiovascular Events
- Hypertension
- Cardiovascular Disease
- Metabolic Syndrome
- Insulin Resistance
- Obesity
- Diabetes
- Endothelial Dysfunction
- Arterial Stiffness
- C-Reactive Protein
- Antihypertensive Drugs
- NAFLD
- Cardiovascular Health
- Adipokines
- Cholesterol-lowering
- Statins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Metabolic Syndrome2714 topics
- Cardiovascular Disease2443 topics
- Insulin Resistance2343 topics
- Hypertension1963 topics
- Obesity1762 topics
- Cardiovascular Events1592 topics
- Diabetes1331 topic
- Glucose Metabolism1331 topic
- Endothelial Dysfunction1282 topics
- Risk Factors1192 topics
- Arterial Stiffness911 topic
- Pulse Wave Velocity911 topic
- C-Reactive Protein802 topics
- Inflammation802 topics
- Antihypertensive Drugs681 topic
- Blood Pressure681 topic
- NAFLD581 topic
- NASH581 topic
- Cardiovascular Health511 topic
- Ideal Cardiovascular Health511 topic
- Adipokines431 topic
- Adipose Tissue431 topic
- Cholesterol-lowering371 topic
- Hyperuricemia371 topic
- Statins371 topic
- Uric Acid371 topic
Where does Shuohua Chen work?
Shuohua Chen's main affiliation in the publication record is Kailuan General Hospital, China.
How many publications and citations does Shuohua Chen have?
OpenAlex counts 526 works and 11,162 citations for Shuohua Chen, an h-index of 49, ranking #187,111 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Shuohua Chen
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shuohua Chen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.